Preparation of targeted theranostic red blood cell membranes-based nanobubbles for treatment of colon adenocarcinoma

References

• Ahmed M. Colon cancer: a clinician’s perspective in 2019. Gastroenterol. Res. 2020;13(1):1–10
   PubMed Web of Science ®Google Scholar
• Schünemann M, Anker SD, Rauchhaus M. Cancer fatigue syndrome reflects clinically non-overt heart failure: an approach towards oncocardiology. Nat. Clin. Pract. Oncol 2008 511. 2008 Sep;5(11): 632–633.
   Google Scholar
• Puts MTE, Sattar S, McWatters K, et al. Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study. Support Care Cancer. 2017;25(3):879–886.
   PubMed Web of Science ®Google Scholar
• Wen Y, Yingze W, Xiaoli L, et al. Camptothecin-based nanodrug delivery systems. Cancer Biol. Med. 2017;14(4):363–370.
   PubMed Web of Science ®Google Scholar
• Ke SZ, Ni XY, Zhang YH, et al. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells. Int J Oncol. 2013;42(4):1289–1296.
   PubMed Web of Science ®Google Scholar
• Holohan C, Van Schaeybroeck S, Longley DB, et al. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013 Oct;13(10):714–726.
   PubMed Web of Science ®Google Scholar
• Zhou F, Feng B, Yu H, et al. Cisplatin prodrug-conjugated gold nanocluster for fluorescence imaging and targeted therapy of the breast cancer. Theranostics. 2016;6(5):679–687.
   PubMed Web of Science ®Google Scholar
• Denardo GL, Denardo SJ. Concepts, consequences, and implications of theranosis. Semin Nucl Med. 2012;42(3):147–150.
   PubMed Web of Science ®Google Scholar
• Siddhardha B, Parasuraman P. Theranostics application of nanomedicine in cancer detection and treatment. In: Grumezescu AM, editor. Nanomaterials for Drug Delivery and Therapy. Norwich, NY, USA: William Andrew Publishing; 2019.
   Google Scholar
• Jin K, Luo Z, Zhang B, et al. Biomimetic nanoparticles for inflammation targeting. Acta Pharm Sin B. 2018;8(1):23–33.
   PubMed Web of Science ®Google Scholar
• Al-Jamal WT, Kostarelos K. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc Chem Res. 2011 Oct;44(10):1094–1104.
   PubMed Web of Science ®Google Scholar
• Hamidi M, Zarrin A, Foroozesh M, et al. Applications of carrier erythrocytes in delivery of biopharmaceuticals. J Control Release. 2007;118(2):145–160.
   PubMed Web of Science ®Google Scholar
• Castro F, Martins C, Silveira MJ, et al. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments. Adv Drug Deliv Rev. 2021;170:312–339.
   PubMed Web of Science ®Google Scholar
• Malhotra S, Dumoga S, Sirohi P, et al. Red blood cells-derived vesicles for delivery of lipophilic drug camptothecin. ACS Appl Mater Interfaces. 2019;11(May):22141–22151.
   PubMedGoogle Scholar
• Zahiri M, Taghavi S, Abnous K, et al. Theranostic nanobubbles towards smart nanomedicines. J Control Release. 2021;339(September):164–194.
   PubMedGoogle Scholar
• Zhang C, Li Y, Ma X, et al. Functional micro/nanobubbles for ultrasound medicine and visualizable guidance. Sci. China Chem. 2021;64(6):899–914.
   PubMed Web of Science ®Google Scholar
• Bezante GP, Girardi N, Agosti S, et al. Contrast echocardiography: the role of sulfur hexafluoride in achieving optimal results. Eur J Echocardiogr. 2006;7(SUPPL. 2):2–7.
   Google Scholar
• Yin T, Wang P, Zheng R, et al. Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomedicine. 2012;7:895–904.
   PubMed Web of Science ®Google Scholar
• Stieger SM, Dayton PA, Borden MA, et al. Imaging of angiogenesis using CadenceTM contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging. 2008;3(1):9–18.
   PubMed Web of Science ®Google Scholar
• Taghavi S, Abnous K, Babaei M, et al. Synthesis of chimeric polymersomes based on PLA-b-PHPMA and PCL-b-PHPMA for nucleoline guided delivery of SN38. Nanomed Nanotechnol Biol Med. 2020;28:102227.
   PubMed Web of Science ®Google Scholar
• Falsafi M, Zahiri M, Saljooghi A, et al. Aptamer targeted red blood cell membrane-coated porphyrinic copper-based MOF for guided photochemotherapy against metastatic breast cancer. Microporous Mesoporous Mater. 2021 Oct;325:111337.
   Web of Science ®Google Scholar
• Zahiri M, Taghdisi SM, Abnous K, et al. Fabrication of versatile targeted lipopolymersomes for improved camptothecin efficacy against colon adenocarcinoma in vitro and in vivo. Expert Opin Drug Deliv. 2021;18(9):1309–1322.
   PubMed Web of Science ®Google Scholar
• Sahranavard M Shahriari M, Abnous K, et al. Design and synthesis of targeted star-shaped micelle for guided delivery of camptothecin: in vitro and in vivo evaluation. Mater Sci Eng C. 2021;131(October):112529.
   PubMedGoogle Scholar
• Shahriari M, Mohammad S, Abnous K, et al. Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer. J Control Release. 2021;335(January):369–388.
   PubMedGoogle Scholar
• Zavvar TS, Babaei M, Abnous K, et al. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model. Int J Pharm. 2020;578(January):119091.
   PubMedGoogle Scholar
• Charbgoo F, Alibolandi M, Taghdisi SM, et al. MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide. Nanomed Nanotechnol Biol Med. 2018;14(3):685–697.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Hoseini F, Mohammadi M, et al. Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma. Int J Pharm. 2018;549(1–2):67–75.
   PubMed Web of Science ®Google Scholar
• Nabavinia MS, Gholoobi A, Charbgoo F, et al. Anti-MUC1 aptamer: a potential opportunity for cancer treatment. Med Res Rev. 2017;37(6):1518–1539.
   PubMed Web of Science ®Google Scholar
• Rao L, Bu LL, Xu JH, Cai B, Yu GT, Yu X, He Z, Huang Q, Li A, Guo SS, Zhang WF. Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance. Small. 2015;11(46):6225–6236.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Luo Z, Men Y, et al. Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy. Biomaterials. 2017;143:29–45.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Taghdisi SM, Ramezani P, et al. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int J Pharm. 2017;519(1–2):352–364.
   PubMed Web of Science ®Google Scholar
• Babaei M, Abnous K, Taghdisi SM, et al. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo. Eur J Pharm Biopharm. 2020;156(August):84–96.
   PubMed Web of Science ®Google Scholar
• Zahiri M, Falsafi M, Lamei K, et al. Targeted biomimetic hollow mesoporous organosilica nanoparticles for delivery of doxorubicin to colon adenocarcinoma: invitro and invivo evaluation. Microporous and Mesoporous Materials. 2022;335:111841.
   Web of Science ®Google Scholar
• Bagheri E, Abnous K, Farzad SA, et al. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer. Life Sci. 2020;261(June):118369.
   PubMedGoogle Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283–318.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Poon W, Tavares A, et al. Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. Journal of Controlled Release 2016;240:332–348.
   PubMed Web of Science ®Google Scholar
• Gref R, Lück M, Quellec P, et al. ‘Stealth’ Corona-core nanoparticles surface modified by polyethylene glycol (PEG). Colloids Surf B Biointerfaces. 2000;18(3–4):301–313.
   PubMed Web of Science ®Google Scholar
• Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today. 2005;10(21):1451–1458.
   PubMed Web of Science ®Google Scholar
• Harris J, C.-n R. Effect of pegylation on pharmaceuticals. Nature Reviews Drug Discovery 2003;2(3):214–221.
   PubMed Web of Science ®Google Scholar
• Gref R, Lück M, Quellec P, et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces. 2000;18(3–4):301–313.
   PubMed Web of Science ®Google Scholar
• Środa K, Rydlewski J, Langner M, et al. Repeated injections of PEG-PE liposomes generate anti-PEG antibodies. Cell. Mol. Biol. Lett. 2005;10(1):37–47.
   PubMed Web of Science ®Google Scholar
• Chanan-Khan A, Szebeni J, Savay S, et al. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Annals of Oncology. 2003;14(9):1430–1437.
   PubMed Web of Science ®Google Scholar
• Malhotra S. “Red blood cells membrane-derived nanoparticles : applications and key challenges in their clinical translation,” no. October. 2022;2021:1–26.
   Google Scholar
• Fonseca LC, De Sousa M, Maia DLS, et al. Understanding the driving forces of camptothecin interactions on the surface of nanocomposites based on graphene oxide decorated with silica nanoparticles. Nanoscale Adv. 2020 Mar;2(3):1290–1300.
   PubMed Web of Science ®Google Scholar
• Sanati S, Taghavi S, Abnous K, et al. Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma. Gene Therapy. 2022;29(1–2):55–68.
   PubMed Web of Science ®Google Scholar
• Zahiri M, Babaei M, Abnous K, et al. Hybrid nanoreservoirs based on dextran-capped dendritic mesoporous silica nanoparticles for CD133-targeted drug delivery. J Cell Physiol. 2020;235(2):1036–1050.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. J Control Release. 2015;209:88–100.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Sadeghi F, Abnous K, et al. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model. Eur J Pharm Biopharm. 2015;94:521–531.
   PubMed Web of Science ®Google Scholar
• Oroojalian F, Babaei M, Taghdisi SM, et al. Encapsulation of thermo-responsive gel in ph-sensitive polymersomes as dual-responsive smart carriers for controlled release of doxorubicin. J Control Release. 2018;288:45–61.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Sadeghi F, et al. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. Int J Pharm. 2015;479(1):241–251.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. Comparative evaluation of polymersome versus micelle structures as vehicles for the controlled release of drugs. J Nanopart Res. 2015;17(2).
   Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. AS1411 aptamer-decorated biodegradable polyethylene glycol-poly(lactic-co-glycolic acid) nanopolymersomes for the targeted delivery of gemcitabine to non-small cell lung cancer in vitro. J Pharm Sci. 2016;105(5):1741–1750.
   PubMed Web of Science ®Google Scholar
• Bagheri E, Alibolandi M, Abnous K, et al. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles. J Mater Chem B. 2021 Feb;9(5):1351–1363.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Rezvani R, Farzad SA, et al. Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int J Pharm. 2017;532(1):581–594.
   PubMedGoogle Scholar
• Andisheh F, Oroojalian F, Shakour N, et al. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo. Int J Pharm. 2021;605(February):120822.
   PubMedGoogle Scholar